Address:
Tel: +353 1 700 5700
The institute draws from the established expertise of researchers in Dublin City University, IT Tallaght and NUI Maynooth with the aim to be a Centre of world-class expertise, in Cellular and Molecular Biotechnology, a diverse and expanding interdisciplinary science. The NICB has combined the variety of expertise of its researchers to develop targeted research programmes in key areas relating to identification of new therapeutic targets and diagnostic methods for disease (in particular for cancer, microbial diseases and diabetes) and understanding of basic biological processes including regulation of gene expression during cell differentiation and their translational to industrial and medical applications.
The NICB is a multidisciplinary centre of research in fundamental and applied Cellular Biotechnology, Molecular Cell Biology, Ocular diseases and Biological Chemistry. It includes a multidisciplinary team of Cell and Molecular Biologists, Biotechnologists. Chemists and Computer scientists.
Niall Barron, director of the NICB, discusses the Institute’s research, which has included significant research into Chinese Hamster Ovary (CHO) cell engineering and the identification of micro-RNA mechanisms that can…
It is widely acknowledged that pharmaceutical manufacturing operations have entered into a period of significant cost reduction. Service providers like Dalkia—a French energy services company that has built its Irish…
“The government’s vision has always been for indigenous companies to develop from the expertise brought in by FDI—and we are seeing that happening now.” Joe Costello, Minister for Trade &…
“The elements that have made Ireland attractive for decades are still here. The big difference since 2007, however, is the cost base. If you are building a pharma plant…
Kells Stainless, founded in 1988, is celebrating 25 years this year. Looking back, what have been the company’s principal achievements over these decades? Originally, Kells Stainless was set up to…
Mr. Murphy, you first joined PM Group 24 years ago. How has the company, and the market, changed? My background, prior to joining PM Group, was in the pharmaceutical industry—I…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a small market and how the industry is adapting to the needs…
Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher…
Can you please introduce yourself, and Ernst & Young’s life science practice in Ireland, to our readers? I am the managing partner of Ernst & Young (EY) in Ireland, responsible…
Can you please introduce our readers to ProTek Medical? ProTek Medical was founded in 1995 to serve a growing healthcare market by partnering closely with our customers in precision injection…
Mr. Callaghan, you have had quite a long and prestigious career in the pharmaceutical industry, with experience overseeing manufacturing programs for giants such as Amgen, BMS and Merck. Can you…
See our Cookie Privacy Policy Here
